SAN DIEGO, May 11 /PRNewswire-FirstCall/ -- NatureWell, Incorporated (BULLETIN BOARD: NAWL) , an emerging researcher, developer, and marketer of proprietary, all-natural healthcare products, announced today its preliminary unaudited April 2007 sales results on a stand alone basis.
Revenue in April 2007 was $50,080 compared to $4,752 in April 2006. This represents an increase of $45,328 or 954%. For the ten months ended April 30, 2007, NatureWell's revenue was $202,150 compared to $40,199 for the ten months ended March 31, 2006. This represents an increase of $161,951 or approximately 403%.
"I'm pleased with our April sales numbers," commented NatureWell, Incorporated's Chairman and Chief Executive Officer, James R. Arabia. "Our sales and customer service representatives continue to open practitioner accounts and raise awareness about MigraSpray through our out-bound telemarketing efforts. We will continue that effort as we explore ways to expand it."
About NatureWell, Incorporated:
NatureWell, Incorporated (http://www.naturewell.com/) is an emerging researcher, developer, and marketer of proprietary, all-natural healthcare products. The Company's flagship product, MigraSpray (http://www.migraspray.com/), is a patented, over-the-counter, homeopathic medicine intended to be a comprehensive approach for the treatment and prevention of migraine headaches.
Statements made in this news release should be considered forward-looking and subject to various risks and uncertainties. Such forward-looking statements are based on management's beliefs and assumptions regarding information currently available, and are made pursuant to the "safe harbor" provisions of the federal securities laws. The Company's actual performance and results could differ materially from those expressed in the forward-looking statements due to certain risks and uncertainties that could materially impact the Company in an adverse fashion and are only predictions of future results, and there can be no assurance that the Company's actual results will not materially differ from those anticipated in these forward-looking statements. Such risks and uncertainties, include, but are not limited to, the Company's ability to secure adequate financing, the Company's ability to ship its products in a timely fashion, volume and timing of orders received, interruption of the manufacturing or distribution of the Company's products or of the supplies or ingredients used to manufacture the Company's products, the effectiveness of the Company's products and consumer perception as to the effectiveness of the products, competitive pricing pressures and the Company's ability to anticipate changes in the market. These and other potential risks and uncertainties are set forth in the Company's filings with the Securities & Exchange Commission. The Company has no obligation to publicly update or revise any of the forward-looking statements that may be in this news release.
